The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
Clinical trial NCT05498467 · COMPLETED
Trial details
- NCT number
- NCT05498467
- Sponsor
- Herlev and Gentofte Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2023-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.